GOLD 2024 COPD Guidelines: What's New in It ?

Поділитися
Вставка
  • Опубліковано 25 лис 2024

КОМЕНТАРІ • 25

  • @mhossain333
    @mhossain333 22 дні тому

    Nice

  • @miraq3261
    @miraq3261 9 місяців тому +1

    Thank you alot dr please keep sharing this video

  • @mariyaasghar7539
    @mariyaasghar7539 4 місяці тому +2

    Excellent presentation. Thank you for putting it all together along with your valuable experience backed input.

  • @mdmajeedr
    @mdmajeedr Рік тому +2

    Thank u for the update great effort .

  • @myhealthislife
    @myhealthislife 11 місяців тому +1

    Thank you!!!

  • @iloveGod1105
    @iloveGod1105 6 місяців тому +1

    This is SO helpful! Thank you SO SO much!!!

  • @docahmer1
    @docahmer1 8 місяців тому +2

    A video on the ESC guidelines for pulmonary embolism would also be useful addition to the basket

  • @chandrashekharrawat1870
    @chandrashekharrawat1870 Рік тому +3

    100 thums-up

  • @alekhyasharma7691
    @alekhyasharma7691 7 місяців тому +1

    Hi maam… can you please make a video on the latest changes in ISHAM abpa guidelines. Many thanks in advance

  • @roshnaraju6878
    @roshnaraju6878 8 місяців тому

    Group a copd predominantly chronic bronchitis which bronchodilator to be given?do patients respond to ics combination better

    • @pulmonologyreadaloud
      @pulmonologyreadaloud  8 місяців тому

      Mainstay of treatment in COPD should be anticholinergics followed by LABA and anticholinergic… add steroids if frequent exacerbation/ eosinophilia more than 300
      Add antibiotics and roflumilast in chronic bronchitis group based on presence of infection/ sectretions

  • @siddharthmishra7071
    @siddharthmishra7071 8 місяців тому

    According to exacerbating definition increase in dyspnea is also an exacerbating so mam kindly please explain term exacerbating what all we have to see

    • @pulmonologyreadaloud
      @pulmonologyreadaloud  8 місяців тому

      The GOLD document defines an exacerbation as “an event in the natural course of the disease characterized by a change in the patient's baseline dyspnoea, cough, and/or sputum that is beyond normal day‐to‐day variations, is acute in onset, and may warrant a change in regular medication in a patient with underlying COPD… so it means anything which is more than his regular daily variation so an increase in his previous breathlessness in case of dyspnea

  • @23dfmahghd
    @23dfmahghd 4 місяці тому

    Is PRISM the same PreCOPD?

    • @pulmonologyreadaloud
      @pulmonologyreadaloud  4 місяці тому +1

      PRISM INCLUDES PRESERVED RATIO BUT SOME IMPAIRMENT IN SPIRO EG FEV1 AND FVC BOTH REDUCED CAUSING NORMAL RATIO ; Patient may not have any symptoms of abnormality
      PRE COPD Means in whom spirometry is unable to detect airflow limitation but in whom the disease is likely to progress ; they may have respiratory symptoms, low-normal FEV1, DlCO, and/or accelerated FEV1 decline; and/or radiographic abnormalities including emphysema

    • @23dfmahghd
      @23dfmahghd 4 місяці тому

      @@pulmonologyreadaloud thank you 🙏🙏🙏

  • @nystagmus
    @nystagmus 10 місяців тому +3

    Why does this keep changing?

    • @iloveGod1105
      @iloveGod1105 6 місяців тому

      Studies showing better outcomes

  • @theeeeeb21
    @theeeeeb21 11 місяців тому

    Thank you so much for great efforts, can you share the presentation ppt with us ? this would be great help

    • @pulmonologyreadaloud
      @pulmonologyreadaloud  11 місяців тому

      Hi Thanks !!.All slides are downloadable at Gold website as part of teaching slide set

    • @theeeeeb21
      @theeeeeb21 11 місяців тому

      @@pulmonologyreadaloud thank you so much , but I ask if you could share this ppt

  • @dr.n.k.maurya7801
    @dr.n.k.maurya7801 7 місяців тому

    Ma'am please provide pdf 🙏🏻